HCV Rapid Antibody, In-home HIV, Advance HIV ½, and oral fluid lab HIV-1/2 test kits.
Closed State & local contract opportunity Posted
- Solicitation number
- SS-11406
- State
- Florida
- Responses due
Opportunity facts
- Jurisdiction
- NIGP codes
- UNSPSC codes
- Point of contact
-
- Yasemin Sulker yasemin.sulker@flhealth.gov (850) 245-4931
Opportunity details come from vendor.myfloridamarketplace.com. Updated .
About this opportunity
The Florida Department of Health (DOH), Bureau of Communicable Diseases, is conducting a single-source procurement for specialized HIV and Hepatitis C test kits through a solicitation targeting OraSure Technologies, Inc. The procurement seeks to acquire HCV Rapid Antibody, in-home HIV, Advance HIV 1/2, and oral fluid lab HIV-1/2 test kits specifically for community outreach and testing among high-risk populations throughout Florida. These test kits must be FDA-approved, capable of providing both HIV positive and negative results within a 20-minute processing time, and suitable for street outreach and non-traditional testing environments. The procurement falls under commodity codes 41113000 and 41116200 for chemical evaluation and patient point-of-care testing supplies. The solicitation was posted on January 13, 2025, with responses due by February 7, 2025, at 5:00 PM, and the contract term is anticipated to be three years. Key objectives include expanding HIV testing opportunities using oral fluid diagnostic methods and rapid testing techniques to reach vulnerable populations.
The procurement is a single-source acquisition targeting OraSure Technologies as the sole manufacturer and distributor of the specified test kits to public health departments. No specific set-aside designations or restrictions for disadvantaged enterprises are mentioned in the documentation. The procurement is limited to OraSure Technologies based on their unique position as the only provider of FDA-approved, CLIA-waived point-of-care rapid tests for Hepatitis C and HIV/AIDS detection. The estimated contract value is $3,000,000.00, covering the three-year contract period. The procurement has been approved by Allegra Small, Purchasing Director, and follows Florida Administrative Code Chapter 60A-1.045 guidelines for single-source procurement. The test kits will be utilized by the DOH's HIV/AIDS section for their community testing and outreach programs, with a focus on reaching high-risk individuals through innovative testing methodologies.
Opportunity text
3 versions
Update #3 · Latest ·
1/27/25 ending date has been extended due to office closures.
------------------
The DOH, Bureau of Communicable Diseases has a need to purchase special test kits, including HCV (Hepatitis C) Rapid Antibody, in-home HIV (Oral fluid Diagnostic) and oral fluid rapid HIV-1/2 antibody test kits (20-minute processing time). These test kits will be used in communities and populations at risk for acquiring HIV and Hepatitis C throughout Florida. Kits must be FDA approved and include testing for both HIV positive and HIV negative results that can be read in 20 minutes due to the critical timeframe while performing the testing during street outreach. This type of testing increases the opportunity for HIV testing in the non-traditional, oral fluid diagnostic method, as well as rapid HIV testing methods, to reach high-risk individuals.
In accordance with Chapter 60A-1.045, Florida Administrative Code, the DOH, Bureau of Communicable Disease, HIV/AIDS section requests authorization to purchase as a single source, HCV Rapid Antibody, in-home HIV OraQuick advance HIV-1/2, and oral fluid lab HIV-1/2 test kids from OraSure.
Update #2 ·
1/21/25 ending date has been extended due to office closures.
------------------
The DOH, Bureau of Communicable Diseases has a need to purchase special test kits, including HCV (Hepatitis C) Rapid Antibody, in-home HIV (Oral fluid Diagnostic) and oral fluid rapid HIV-1/2 antibody test kits (20-minute processing time). These test kits will be used in communities and populations at risk for acquiring HIV and Hepatitis C throughout Florida. Kits must be FDA approved and include testing for both HIV positive and HIV negative results that can be read in 20 minutes due to the critical timeframe while performing the testing during street outreach. This type of testing increases the opportunity for HIV testing in the non-traditional, oral fluid diagnostic method, as well as rapid HIV testing methods, to reach high-risk individuals.
In accordance with Chapter 60A-1.045, Florida Administrative Code, the DOH, Bureau of Communicable Disease, HIV/AIDS section requests authorization to purchase as a single source, HCV Rapid Antibody, in-home HIV OraQuick advance HIV-1/2, and oral fluid lab HIV-1/2 test kids from OraSure.
Update #1 ·
The DOH, Bureau of Communicable Diseases has a need to purchase special test kits, including HCV (Hepatitis C) Rapid Antibody, in-home HIV (Oral fluid Diagnostic) and oral fluid rapid HIV-1/2 antibody test kits (20-minute processing time). These test kits will be used in communities and populations at risk for acquiring HIV and Hepatitis C throughout Florida. Kits must be FDA approved and include testing for both HIV positive and HIV negative results that can be read in 20 minutes due to the critical timeframe while performing the testing during street outreach. This type of testing increases the opportunity for HIV testing in the non-traditional, oral fluid diagnostic method, as well as rapid HIV testing methods, to reach high-risk individuals.
In accordance with Chapter 60A-1.045, Florida Administrative Code, the DOH, Bureau of Communicable Disease, HIV/AIDS section requests authorization to purchase as a single source, HCV Rapid Antibody, in-home HIV OraQuick advance HIV-1/2, and oral fluid lab HIV-1/2 test kids from OraSure.
Files
| File | Type | Posted |
|---|---|---|
| EXP2600_PUR7776 Final.pdf | ||
| EXP2600_PUR7776 Final.pdf | ||
| EXP2600_PUR7776 Final.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity